Brooks, J. D., Comen, E. A., Reiner, A. S., Orlow, I., Leong, S. F., Liang, X., . . . Bernstein, J. L. (2018). CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study. Breast Cancer Res.
Citação norma ChicagoBrooks, Jennifer D., et al. "CYP2D6 Phenotype, Tamoxifen, and Risk of Contralateral Breast Cancer in the WECARE Study." Breast Cancer Res 2018.
MLA CitationBrooks, Jennifer D., et al. "CYP2D6 Phenotype, Tamoxifen, and Risk of Contralateral Breast Cancer in the WECARE Study." Breast Cancer Res 2018.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.